Pharmaceutical Wholesalers Call for Increased Funding and Stricter Oversight of Medicine ShippersThe German Association of Pharmaceutical Wholesalers (Phagro) is advocating for stronger regulatory measures and enhanced compensation within the framework of the proposed Pharmacy Care Advancement Act (ApoVWG). Central to Phagro's position is the recommendation that oversight of logistics companies involved in the distribution of prescription medicines be formally established under the German Medicines Act (AMG). In addition to regulatory concerns, Phagro is seeking a revision of the current compensation model for pharmaceutical wholesalers. Phagro is critical of the mandatory participation in a planned electronic reporting system, arguing that it infringes upon the professional autonomy of pharmaceutical wholesalers. As legislative discussions continue, stakeholders are urging policymakers to consider the practical implications of new regulations for wholesalers, pharmacies, and logistics providers alike.
